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Abstract: There is an increasing demand for products from natural sources, which includes a growing
market for naturally-produced colorants. Filamentous fungi produce a vast number of chemically
diverse pigments and are therefore explored as an easily accessible source. In this study we examine
the positive regulatory effect of the transcription factor AurR1 on the aurofusarin gene cluster in
Fusarium graminearum. Proteomic analyses showed that overexpression of AurR1 resulted in a
significant increase of five of the eleven proteins belonging to the aurofusarin biosynthetic pathway.
Further, the production of aurofusarin was increased more than threefold in the overexpression
mutant compared to the wild type, reaching levels of 270 mg/L. In addition to biosynthesis of
aurofusarin, several yet undescribed putative naphthoquinone/anthraquinone analogue compounds
were observed in the overexpression mutant. Our results suggest that it is possible to enhance the
aurofusarin production through genetic engineering.
Keywords: aurofusarin; PKS12; secondary metabolites; polyketide; natural products; aurR1; Fusarium;
pigment; fungi; mycotoxins
Key Contribution: Overexpression of the transcription factor AurR1 results in tripled production
of aurofusarin.
1. Introduction
The fungal polyketides are a diverse group of natural products that comprises of mycotoxins,
clinical important drugs, and pigments [1–3]. Examples of the first two are fusarielins and
lovastatin, which are shown to stimulate MCF-7 cell proliferation or commercially used against
hypercholesterolemia, respectively [4–6]. The pigment aurofusarin, which is the target of this study,
is a homodimeric naphthoquinone produced by crop molds of the genus Fusarium and is often
associated with naturally infected wheat where the compound can occur in high levels [7].
Aurofusarin was initially described in 1937 as a golden yellow micro-crystalline pigment but the
chemical structure was not elucidated until 1966 [8–11]. The PKS12 gene cluster from Fusarium graminearum
was identified to be responsible for aurofusarin biosynthesis under the control of the local transcription
factor AurR1 [12,13]. Kim and colleagues showed that the knock-out of aurR1 resulted in complete
absence of pigmentation and that re-integration of a constitutively expressed aurR1 gene into the
knock-out mutant led to increased aurofusarin production compared to the wild-type (wt) [12].
Besides aurR1, the PKS12 gene cluster contains ten genes encoding a polyketide synthase (PKS12),
a rubrofusarin pump (AurT), a laccase not required for aurofusarin production (AurL2), a second
transcription factor (AurR2), and six tailoring enzymes [14]. The transcription factor AurR2 possibly
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acts as a co-regulator of the PKS12 gene cluster. Deletion of aurR2 results in an altered ratio of
rubrofusarin to aurofusarin [14].
The PKS12 gene cluster is responsible for the production of several other compounds including
YWA1, rubrofusarin, and fuscofusarin [15,16]. The aurofusarin biosynthetic pathway can be redirected
to produce citreoisocoumarin by changing nitrogen sources and pH [17]. Further, the laccase catalyzing
monomeric activation resulting in radical-mediated dimerization could potentially lead to several
other dimerization patterns than that present in aurofusarin [14].
Naphthoquinones, including dimeric naphthoquinones, have previously been described as having
antibiotic activity against both Gram-positive and Gram-negative bacteria, as well as yeast of the genus
Candida [18,19]. In fact, 22 naphthoquinones from F. solani and F. oxysporum were examined by Baker
and colleagues, of which 12 were antimicrobial against Streptococcus pyogenes and 15 were active against
Staphylococcus aureus [20]. Aurofusarin was shown to inhibit probiotic bacteria, which might shift the
gut microbes to a more harmful constitution causing illness and diarrhea [21]. Also, aurofusarin is
cytotoxic, genotoxic, and induces oxidative stress in human colon cells [22].
Cytotoxicity and antibiotic activity of naphthoquinones from the PKS12 pathway of F. graminearum
should be more thoroughly investigated, including animal trials to assess aurofusarin’s
antibacterial/toxicological effect when ingested through feed. However, this requires large quantities
of the compound, which is very expensive. To accommodate this, we aimed to make aurofusarin and
derivatives thereof more readily available. The wt F. graminearum produces aurofusarin under several
growth conditions, often as one of the most abundant secondary metabolites. Therefore, we chose
an over-expression strategy that contributed to the natural expression machinery by additionally
expressing the aurR1 gene in an ectopic position close to the β-tubulin locus. Furthermore, we describe
a method for pigment extraction directly from liquid growth media, resulting in the detection of four
putative yet undescribed naphthoquinones.
2. Results and Discussion
AurR1 is a positive-acting transcription factor, influencing the expression of several genes in the
aurofusarin gene cluster. To investigate the upregulation of the PKS12 gene cluster, the transcription
factor aurR1 was expressed in an ectopic position next to the β-tubulin gene. The transcription factor
was under control of the constitutive TEF promotor. The resulting OE::aurR1 mutant was sequenced
to approximately 200× coverage (Supplementary Figure S1) to verify the correct integration of the
insert. To determine the protein expression level, protein was extracted from dried mycelial powder of
both OE::aurR1 and the wt and analyzed using shotgun proteomics. Seven out of ten proteins from
the aurofusarin gene cluster were detected, of which five showed significantly increased expression
(p < 0.05) in the OE::aurR1 mutant when comparing label-free quantification (LFQ) values (Table 1
and Figure 1a) [23]. We also compared three housekeeping genes to evaluate the performance of the
method for which we observed no difference between the mutant and the wt. These were β-tubulin
(UniProt ID: I1RR95), H+-ATPase (UniProt ID: I1RCU4), and TEF-1α (UniProt ID: I1R.W.X5) with
p-values calculated to be 0.4, 0.5, and 0.5, respectively (Figure 1b). The p-value for AurZ was calculated
to be 0.07 and was therefore slightly above the threshold for statistical significance. However, two out
of three LFQ values for AurZ in the wt were imputed to reflect low abundant proteins, which might
have caused an overestimation of the actual p-value [24]. There was no statistical significant difference
in expression for AurT (p = 0.32) between the mutant and the wt, indicating either that AurR1 does
not affect the transcription of aurT or, perhaps more likely, the applied method for protein extraction
does not favor membrane bound proteins [25]. The mutant to the wt LFQ ratios for detected proteins
from the cluster were calculated to be between 4.5 and 11.2, with the exception of AurT, which was
at 1.6. Expectedly, AurR1 and AurR2 were not detected. Transcription factors are known to have
unstable mRNA and proteins, both contributing to low abundance [26]. Additionally, detection of
compartmentalized and DNA binding proteins, such as transcription factors, benefit from selective
purification and enrichment procedures [27]. AurL2 and AurS were not detected, probably due to low
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abundance. It could be expected that the expression of aurL2 would not be influenced by AurR1 as it is
not required for aurofusarin biosynthesis [14]. AurS contains a transmembrane helix (InterPro [28] and
Pfam [29]) indicating that this protein is anchored to the cell membrane, which could lead to reduced
solubility and yield in the protein extraction.
Table 1. The PKS12 gene cluster in F. graminearum. Predicted protein function by Pfam or InterPro.
Locus Name UniProt ID Predicted Function Mutant (LFQ)/Wt (LFQ)
FG02320 AurR1 I1RF54 Positive acting transcription factor
FG02321 AurO I1RF55 Oxidoreductase 4.5
FG02322 AurT I1RF56 Rubrufusarin pump 1.6
FG02323 AurR2 I1RF57 Transcription factor
FG02324 PKS12 I1RF58 Polyketide synthase producing YWA1 10.8
FG02325 AurZ I1RF59 Dehydratase 4.6
FG02326 AurJ I1RF60 O-methyltransferase 8.4
FG02327 AurF I1RF61 Monooxygenase 11.2
FG02328 Gip1 I1RF62 Cu-oxidase 7.9
FG02329 AurS I1RF63 Fasciclin-like domain containing protein
FG02330 AurL2 1 I1RF64 Cu-oxidase
1 Is not required for aurofusarin production.
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two-tailed Student’s t-test. Missing/undetected values from the wild type were imputed to reflect low-
abundant proteins. 
When comparing intensity-based absolute quantification (iBAQ) values, the most abundant 
protein from the PKS12 cluster in both the wt and the mutant was AurO closely followed by AurJ 
(Figure 2) [26]. In the mutant, these two proteins are expressed as the sixth and eighth most abundant 
within the 908 proteins quantified. Comparing OE::aurR1 and the wt, all observed proteins of the 
PKS12 cluster have become more abundant compared to other cellular proteins. If one sorts the 
proteins or the PKS12 cluster by abundance, their relative order is maintained when going from the 
wt to OE::aurR1, with the exception of AurF which went from sixth in the wt to third in the mutant. 
As the p-values in Table 1 already indicate, there is no significant difference in expression for AurT 
Figure 1. The PKS12 gene cluster (a) and housekeeping genes (b) with mean log2 (label-free
relative quantification) intensities of identified proteins and standard error bars calculated from three
biological replicates of OE::aurR1 and t gro n on Cz ediu . The p-values are calculated from a
two-tailed Student’s t-test. Missing/undetected values from the wild type were imputed to reflect
low-abundant proteins.
When comparing intensit - l t tifi ti (i ) alues, the ost abundant
protein from the PKS12 cluster in bot t t t t t s r cl sely followed by AurJ
(Figure 2) [26]. In the utant, t ese t o rotei s are ex resse as t e sixt and eighth most abundant
within the 908 proteins quantified. o paring E::aur 1 and the t, all observed proteins of the
PKS12 cluster have beco e ore abundant co pared to other cellular proteins. If one sorts the
proteins or the PKS12 cluster by abundance, their relative order is aintained hen going from the
wt to OE::aurR1, with the exception of AurF which went from sixth in the wt to third in the mutant.
As the p-values in Table 1 already indicate, there is no significant difference in expression for AurT
between the mutant and the wt. Either AurR1 does not affect the expression of aurT, or AurR1 affects
the expression of aurT, albeit to a lesser extent compared to the other proteins in the cluster.
Toxins 2018, 10, 485 4 of 11
Toxins 2018, 10, x FOR PEER REVIEW  4 of 11 
 
between the mutant and the wt. Either AurR1 does not affect the expression of aurT, or AurR1 affects 
the expression of aurT, albeit to a lesser extent compared to the other proteins in the cluster. 
 
Figure 2. Scatter plots of 908 identified proteins sorted from highest to lowest log2 (intensity-based 
absolute quantification) intensities calculated from three biological replicates of OE::aurR1 and the wt 
grown on a Cz medium. The proteins from the PKS12 gene cluster are highlighted and the dotted 
lines show the correlation between OE::aurR1 and the wt. The wt plot is downshifted by five log2 
units. 
The phenotype of the OE::aurR1 mutant appeared deep red with yellow aerial mycelium when 
grown for six days on a solid Cz medium (Figure 3a) compared to the wt, which was pale red/pink 
with white aerial mycelium. An aurR1 knockout mutant previously described by Frandsen and 
colleagues in 2006 was cultured simultaneously and, as expected, exhibited complete lack of 
coloration [14]. Cultures of OE::aurR1 and the wt were grown in liquid Cz medium for three days, at 
which point a clear difference in coloration was observed (Figure 3b). The wt culture was pale-
yellowish while the mutant displayed a dark red-brownish color. Aurofusarin, and derivatives 
thereof, contain conjugated systems absorbing visible light at longer wavelengths, which could 
explain the observed difference. Metabolites were extracted directly from the medium from two 
individual 1 L cultures of both the mutant and the wt grown for three days and the concentration of 
aurofusarin was measured using quantitative 1H-NMR. Expectedly, the mutant produced the most 
aurofusarin with concentrations calculated at 36.3 and 39.7 mg/L compared to 8.9 and 13.7 mg/L for 
the wt. The mutant thereby produced between 2.6 and 3.4 times more aurofusarin than the wt, 
supporting the proteomics data. 
 
Figure 3. Color differences of wild type and mutants. (a) Wild type Fusarium graminearum (wt), aurR1 
knockout mutant (KO::aurR1), and OE::aurR1 grown on a Cz agar medium for 6 days. (b) Cultures of 
Figure 2. Scatter plots of 908 identified proteins sorted from highest to lowest log2 (intensity-based
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show the correlation between OE::aurR1 and the wt. The wt plot is downshifted by five log2 units.
The phenotype of the OE::aurR1 mutant appeared deep red with yellow aerial mycelium when
grown for six days on a solid Cz medium (Figure 3a) compared to the wt, which was pale red/pink with
white aerial mycelium. An aurR1 knockout mutant previously described by Frandsen and colleagues
in 2006 was cultured simultaneously and, as expected, exhibited complete lack of coloration [14].
Cultures of OE::aurR1 and the wt were grown in liquid Cz medium for three days, at which point a
clear difference in coloration was observed (Figure 3b). The wt culture was pale-yellowish while the
mutant displayed a dark red-brownish color. Aurofusa in, and derivatives thereof, contain conjugated
systems absorbing visible light at longer wavelengths, which could xpl in the observed difference.
Metabolites were extracted dire tly from th medium from two individual 1 L cultures f both the
mutant and the wt grown for three days and the concentration of aurofusarin was measured using
quantitative 1H-NMR. Expectedly, the mutant produced the most aurofusarin with concentrations
calculated at 36.3 and 39.7 mg/L compared to 8.9 and 13.7 mg/L for the wt. The mutant thereby
produced between 2.6 and 3.4 times more aurofusarin than the wt, supporting the proteomics data.
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Figure 3. Color differences of wild type and utants. (a) ild type Fusarium graminearum (wt), aurR1
knock ut mutant (KO::aurR1), and :: r 1 grown on a Cz gar medium for 6 days. (b) Cultures
of wt and OE::aurR1 grown for 3 days in a liquid Cz medium. 1H-NMR quantification of aurofusarin
from biological duplicates are indicated in mg/mL.
The final step in the aurofusarin biosynthetic pathway is a dimerization of rubrofusarin to
aurofusarin, which is predicted to be catalyzed by an extracellular enzyme complex consisting of Gip1,
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AurF, AurO, and AurS [15]. Gip1 is a predicted laccase with a multicopper oxidase domain and we
therefore hypothesized that the availability of copper ions could influence aurofusarin production in
the overexpression mutant. However, ranging the concentration from 10 to 80 µM CuSO4 × 5H2O did
not significantly affect aurofusarin production. The highest average production was observed at 10 µM
CuSO4 × 5H2O, which yielded 270 mg/L aurofusarin after seven days of growth (Supplementary
Figure S2).
The extracted compounds from the OE::aurR1 culture were analyzed using HPLC-DAD-HRMS
(Figure 4). Five peaks (A-E) were observed from a UV chromatogram (400 nm) with UV spectra similar
to that of aurofusarin (spectrum B). The UV spectrum of aurofusarin has two peak maxima at 244 and
268 nm and a broad peak at 381 nm, with a UV(244)/UV(268) absorption ratio around 1.5. A similar
ratio was observed for peak A; however, the ratio had shifted to 0.9 for peak C. The absorption
ratios for peak D and E were calculated at 0.6 and 0.4, respectively. Eleven masses were observed,
which corresponded to compounds with chemical formulae comparable to that of aurofusarin or
possible analogues (Table 2). Peak B had a [M + H]+ at 571.09 Da corresponding to aurofusarin.
Further, the [M + H]+ for peak D was measured at 557.11 Da corresponding to fuscofusarin. Peak A
aligned with a [M + H]+ of 557.07 Da fitting the chemical formula C29H16O12, which is comparable
to that of aurofusarin with the loss of CH2. This could be explained by one of the monomers of
aurofusarin lacking an O-methylation, which could also explain the lower retention time. Peak C
was measured at 573.10 Da [M + H]+ corresponding to aurofusarin with an increased mass of
two hydrogens. Finally, peak E had a mass at 543.13 giving a chemical formula of C30H22O10.
Compared to aurofusarin, this compound has an increase of four hydrogen atoms and a loss of
two oxygen atoms. This could be explained by a homodimerization of rubrofusarin, which was also
proposed by Frandsen in 2006 [14]. The remaining six masses [M + H]+ were measured at 587.08 Da
(C30H18O13, aurofusarin + O), 603.08 Da (C30H18O14, aurofusarin + 2O), 589.10 Da (C30H20O13,
aurofusarin + H2O), 575.12 Da (C30H22O12, aurofusarin + 4H), 541.08 (C29H16O11, aurofusarin −
CH2O), and 273.08 Da (rubrofusarin). When over-expressing a local transcription factor from a
secondary metabolite cluster, it could be expected that the natural ratio and abundance of modifying
enzymes was changed, which might result in alternative routes for the biosynthetic machinery.
This could explain the proposed naphthoquinone derivatives observed from the OE::aurR1 metabolite
extract. A database search for known naphthoquinone/anthraquinone natural products employing
Reaxys and PubChem could not identify any possible candidates for peaks 1–4 indicating that these
might be yet undescribed compounds.
Table 2. List of selected masses from Figure 4 number 1–11 (#) including retention time (RT), observed
charged mass ([M + H]+), proposed chemical formula, and the compound name/modification relative
to aurofusarin.
# RT (min) Mass [M + H]+ Chemical Formula Name/Variation
1 10.2; 12.9 1; 13.4; 14.3 587.0820 2 C30H18O13 +O
2 10.9 (A); 11.7 557.0715 2 C29H16O12 −CH2
3 12.5 603.0769 2 C30H18O14 +2O
4 12.9 589.0977 2 C30H20O13 +H2O
5 13.6 (B); 14.1 (C) 571.0871 C30H18O12 aurofusarin
6 13.6 1 (B); 14.1 (C) 573.1027 C30H20O12 +2H
7 14.11 (C); 14.7 575.1184 C30H22O12 +4H
8 15.2 541.0765 C29H16O11 −CH2O
9 15.7 273.0758 C15H12O5 rubrofusarin
10 15.8 (D) 557.1078 C30H20O11 fuscofusarin
11 17.7 (E) 543.1286 C30H22O10 −2O + 4H
1 The observed EIC peak was caused by an isotopomer of a different compound or by a compound with a closely
related mass. 2 Chemical formulae that does not match any natural products with a naphthoquinone/anthraquinone
structure based on a Reaxys and PubChem database search.
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3. Conclusions
In the present study, we have described the changes of protein expression and secondary
metabolite production when the local transcription factor AurR1 is over-produced. Five of the seven
detected proteins from the PKS12 cluster were observed to be significantly increased in the AurR1
over-producing mutant. In general, all proteins from the cluster were more abundant relative to the
total cell protein in the mutant compared to the wt; however, the transporter AurT was affected to a
lesser extent. The mutant produced between 2.6 and 3.4 times the amount of aurofusarin compared to
the wild type with a maximal observed mean production of 270 mg/L. The availability of copper ions
did not affect aurofusarin production, but future studies with other factors, such as a nitrogen and
carbon source, temperature, and aeration can perhaps be more successful. The mutant was shown to
produce several compounds with chemical formulae comparable to aurofusarin analogues, four of
which had no match to known naphthoquinone/anthraquinone natural products. The extraction
of aurofusarin and related compounds directly from the media enabled faster and more efficient
production of aurofusarin, which could easily be implemented to flow reactors.
4. Materials and Methods
4.1. Generation and Verification of aurR1 Overexpression Mutant
aurR1 (FGSG_02320) was amplified using PCR using the primers PaurR1_Fw (5′-ACGTCGG
ATCCATGAGTTCCACAGACCCCCTTCT-3′) and PaurR1_Rv (5′-ACGTCTCTAGACTACTTGAC
CTCGAGCTTCTTTCGT-3′) (Eurofins Genomics, Ebersberg, Germany) holding restriction sites for
BamHI and XbaI, respectively. PCR was conducted with PfuTurbo Cx Hotstart DNA Polymerase
(Agilent, Santa Clara, CA, USA) using genomic DNA from F. graminearum PH-1 (NRRL 31084) as a
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template. The amplified aurR1 PCR fragment was cloned into a U-GOTL vector, which is a modified
version of the U-GOAL vector [30]. The U-GOTL vector has border regions targeting the β-tubulin
locus. The cloned vector was verified using colony PCR and sequencing of the integrated site by
Eurofins Genomics.
The vector was electroporated into Agrobacterium tumefaciens LBA4404 obtained from Invitrogen,
Thermo Fisher Scientific Inc. catalog number: 18313-015, which was subsequently used to transform
macroconidia of F. graminearum as previously described [31]. The macroconidia were obtained from a
5-day culture grown in a carboxymethylcellulose medium (CMC) (15 g/L sodium carboxymethylcellulose
medium viscosity (MP Biomedicals, Solon, OH, USA), 1 g/L NH4NO3, 1 g/L KH2PO4, 0.5 g/L
MgSO4·7H2O, 1 g/L yeast extract (Difco Lboratories, Detroit, MI, USA)) in the dark at 20 ◦C with
150 rpm. The aurR1 overexpression mutants were selected for by growing on a defined Fusarium
medium containing 300 µg/mL of geneticin (Sigma-Aldritch, St. Louis, MO, USA), and the correct
insertion of the aurR1 gene was verified by full genome sequencing.
Fungal DNA was extracted with the FastDNA SPIN Kit for Soil (MP Biomedicals) and cleaned
with Agencourt AMPure XP beads (Beckman Coulter, Brea, CA, USA).
A Nextera paired-end DNA library (Illumina, San Diego, CA, USA) was prepared according
to the manufacturers description, with the modification of using Agencourt AMPure XP beads
(0.7 bead:sample ratio) for the post-tagmentation clean-up. The quality of the purified DNA was
measured using a NanoDrop ND-1000 (Thermo Scientific, Waltham, MA, USA), a D1000 ScreenTape
system (Agilent, Santa Clara, CA, USA), and using the Qubit dsDNA HS assay kit (Thermo
Scientific, USA).
The paired-end library was sequenced to approximately 200× coverage on the Illumina HiSeq
2500 system using the Rapid SBS Kit v2 (2 × 250 cycles). The data were trimmed for low quality
reads, ambiguous nucleotides, and adaptors in CLC Genomics Workbench v. 9.4.2 (Qiagen, Vedbæk,
Denmark). Following read-merging, reads were mapped to a reference genome (PH1) and further
assessed for random insertion using a de novo assembly approach.
4.2. Proteomics
Triplicate cultures of OE::aurR1 and the wild type were grown in Liquid Czapek Dox (Cz)
medium (30 g/L sucrose, 3 g/L NaNO3, 1 g/L K2HPO4, 0.5 g/L MgSO4·7H2O, 0.5 g/L KCl, 0.01 g/L
FeSO4·7H2O, 16 mg/L ZnSO4·7H2O, 5 mg/L CuSO4·5H2O, pH 6.25) at 25 ◦C with 100 rpm for five
days. The cultures were filtered through MiraCloth (Calbiochem, Merck, Darmstadt, Germany) and the
fungal mycelium was lyophilized. Protein concentration was determined from 10 mg of dried fungal
powder suspended in 500 µL of cold sterile H2O. The solution was heated to 95 ◦C for 10 min and
afterwards cooled on ice. The samples were centrifuged for 5 min at 14,100× g, and the supernatant
was transferred to new tubes. The samples were centrifuged a second time for 5 min at 14,100× g and
the protein concentration was measured using Qubit.
Samples for the proteomic analyses were processed using a polyvinylidene fluoride membrane-based
proteomic sample preparation approach as described elsewhere [32]. In short, approximately 20 µg of
protein was suspended in urea buffer for denaturation, and was reduced and carbamidomethylated
before in-solution trypsin digestion. Clean-up was performed by washing and elution from the
membrane. Tryptic peptides were measured using nLC-MS/MS (Ultimate 3000 coupled to a Q
Exactive, Thermo Fisher Scientific, Waltham, MA, USA) applying a 3 h method (≈140 min elution
window), where details can be found elsewhere [33]. Mass spectra were analyzed using MaxQuant
(version 1.5.3.30, Max Planck Institute of Biochemistry, Martinsried, Germany) [34] as previously
described [33]. Besides activation of label-free quantification by the MaxQuant label-free quantification
algorithm [35] and iBAQ calculations [26], settings were kept on default. This includes a false-discovery
rate of maximum 1% on peptide and protein level. An organism-specific protein database in FASTA
file format was obtained from UniProt [36].
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The LFQ and iBAQ data matrix’s were imported into Perseus (version 1.5.6.0, Max Planck Institute
of Biochemistry, Martinsried, Germany) [37] and grouped into either OE::aurR1 or wt. The data was
filtered to remove proteins that were only identified by site, reverse, and potential contaminants.
Further, all proteins must be represented by at least two valid values larger than 0 in at least one of
the groups. The values were log2(x) transformed, and missing values were imputed from a normal
distribution of the whole matrix using a width of 0.3 and a downshift of 1.8 to represent low abundant
proteins. A two-tailed Student’s t-test was applied to determine whether protein concentration levels
differed significantly between the OE::aurR1 and wild type cultures. Statistical significance was defined
as a p-value ≤ 0.05.
4.3. Metabolite Extraction from Liquid Growth Medium, NMR Quantification, and LCMS
One L Cz media was inoculated with 5 × 103 spores of OE::aurR1 or the wild type and incubated
in a 2 L Erlenmeyer flask with three baffles at 25 ◦C and 100 rpm for 3 days in complete darkness,
both in duplicates. The growth media was filtrated through Miracloth. 300 mL media in a 1 L bluecap
bottle, and was acidified with 20 mL 5 M HCl and shaken. The color of the media was observed
to change from dark brown to yellow. Three hundred milliliters of chloroform was added and the
mixture was shaken. After settling, the color could be observed in the water phase. Two hundred
milliliters of methanol was added and the mixture was shaken vigorously. The phases were allowed
to settle and a yellow coloration was now observed in the organic phase. Most of the water phase
was carefully decanted. Two hundred milliliters of 10% w/v NaCl in demineralized water was added
to the chloroform together with 100 mL of methanol. The mixture was shaken and the phases were
allowed to settle. The organic phase was collected using a separating funnel. The solvent was removed
using rotary evaporation in vacuo at 40 ◦C.
The dried metabolite extracts were re-dissolved in 12 mL of chloroform and analyzed using
LC-MS. Sixty microliters of each sample were dried under N2 gas and dissolved in 600 µL chloroform-d
(99.8 atom % D, 0.03% TMS, Euriso-Top GmbH, Saarbrücken, Germany) and analysed by NMR.
1H and 1H-PULCON [38] spectra were recorded on a Bruker AVIII-600 MHz spectrometer (Bruker,
Karlsruhe, Germany) equipped with a triple resonance cryogenically cooled probe with z-gradients
and controlled by TopSpin 3.5pl6. All recordings were performed in chloroform-d at 298.1 K and
calibrated to TMS 1H (0 ppm).
Extracts from OE::aurR1 were analyzed using HPLC-DAD-HRMS on a Hitachi Elite LaChrom
HPLC system (Hitachi Ltd., Tokyo, Japan) equipped with an L-2130 pump, L-2200 autosampler,
L-2300 column oven at 40 ◦C with a C6-phenyl column (150 × 4.6 mm Ascentis Xpress 2.7 µm,
Sigma-Aldrich, St. Louis, MO, USA), and an L-2450 DAD detector. The system was coupled through a
5:95 flowsplitter to a high-resolution mass spectrometer (Compact qTOF, Bruker, Karlsruhe, Germany)
with an electrospray source (Capilary: 4500 V; end plate offset 500 V; dry gas 4.0 L/min, 200 ◦C) and
run in positive mode. The 1 mL/min gradient initiated at 90% solvent A (water, HiPerSolv, VWR,
Radnor, PA, USA) and 10% solvent B (acetonitrile, Hypersolve, VWR, Radnor, PA, USA), were both
supplemented with 0.1% formic acid (MS grade 98%, Sigma-Aldrich), increasing linearly to 100%
solvent B over 20 min and held for 5 min. Twelve seconds after sample injection, a 2 µL calibrant
solution (10 mM NaOH and 26 mM formic acid in 1:1 MS-grade H2O:isopropanol) was injected into
the mass spectrometer.
4.4. Production of Aurofusarin in Response to Copper Availability
Prior to experiments, spores of OE::aurR1 were produced in 50 mL of liquid CMC medium by
shaking at 150 rpm and 20 ◦C for four days [39]. The macroconidia were resuspended in sterile H2O
after two rounds of centrifugation to reach a concentration of 3.5 × 106/mL. One hundred microliters
of the spore solution was added to 250 mL baffled flasks containing 100 mL of Czapek dox medium [40]
to which 0.1 mL ZnSO4 × 7 H2O (1 g/100 mL) was added together with 0.1 mL CuSO4 × 5 H2O (0.25,
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0.5, 1, 2, 3, or 4 g/100 mL). The flasks were incubated in a dark shaking incubator at 120 rpm for one
week at 25 ◦C.
To determine the aurofusarin production, 1 mL of medium was transferred to a micro centrifuge
tube and spun for two minutes at 12,000 rpm to remove impurities. A 10 µL sample was then transferred
to an HPLC vial and diluted with 990 µL of methanol. Aurofusarin was quantified using HPLC-MS/MS
as given previously using a two-fold dilution series ranging from 0.019–10 mg/L [41,42].
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/10/11/485/
s1, Figure S1: Sequencing results for the OE::aurR1 mutant, Figure S2: Production of aurofusarin in the OE::aurR1
mutant in response to variable concentration of copper.
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